Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I-IIa, Randomized, Controlled, Open-label, Single-center Clinical Trial to Evaluate Safety, Feasibility, and Efficacy of the Use of BIOCLEFT in the Treatment of Patients With Cleft Palate

NCT06408337 is registered in ClinicalTrials.gov with Elisa María Cubiles Montero de Espinosa as lead sponsor.

NCT NCT06408337
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06408337 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I-IIa, Randomized, Controlled, Open-label, Single-center Clinical Trial to Evaluate Safety, Feasibility, and Efficacy of the Use of BIOCLEFT in the Treatment of Patients With Cleft Palate
Lead sponsor
Elisa María Cubiles Montero de Espinosa
Phase
Phase 1/2
Overall status
Recruiting
Start date
April 17, 2024
Completion date
December 17, 2028
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cleft lip and palate